Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This compound demonstrates superior efficacy in glucose regulation studies compared to selective GLP-1 receptor agonists.
The molecular mechanism of tirzepatide involves simultaneous activation of both GIP and GLP-1 receptors, with preferential binding affinity for GIP receptors. This unique pharmacological profile has shown promising results in preclinical metabolic research models.
Our tirzepatide compound is manufactured under strict quality control standards, ensuring high purity (>99%) and consistent batch-to-batch reliability for research purposes. The white powder form allows for convenient handling and preparation of research solutions.
For laboratory use only, this product is not intended for human consumption. Researchers should follow appropriate safety protocols when handling tirzepatide compound.
Storage recommendations include maintaining the compound at 0-4°C for short-term use or -20°C for long-term preservation. Proper storage conditions help maintain the stability and integrity of the research material.
When you buy tirzepatide compound UK from our facility, you receive pharmaceutical-grade material suitable for various research applications in metabolic studies and related scientific investigations.
Our production capabilities allow for both standard batch supply and custom synthesis of tirzepatide compound to meet specific research requirements. Bulk quantities are available for institutional research programs.
The potential research applications of tirzepatide compound include studies in glucose metabolism, insulin signaling pathways, and weight regulation mechanisms. Researchers interested in buy tirzepatide compound UK for metabolic studies can rely on our high-quality supply.